Agentic AI systems are entering healthcare workflows faster than institutions can build the necessary governance structures, creating a structural accountability gap. Healthcare organizations are acquiring these tools using procurement processes designed for standard equipment, leaving clinicians legally responsible for automated decisions they cannot fully interrogate.
The governance blind spot
Agentic AI initiates, sequences, and acts across functional boundaries simultaneously. It does not wait for a workflow to invite it in or produce a single traceable decision point. The modern patient safety movement assumed the human remained visible, interruptible, and accountable in the causal chain. Agentic AI inverts this dynamic by introducing a system that performs well enough to erode the vigilance required for safety.
This creates a categorical mismatch between the architecture of the tool and the institution deploying it. Procurement decisions evaluate these systems on cost, compliance and vendor credibility rather than clinical workflow fit or accountability mapping. Innovations are deployed into unchanged workflows and handed to clinicians whose professional standards have not adapted. The result is a reality where "when deployment outpaces integration, technology does not resolve fragmentation. It compounds it."
The human-on-the-loop reality
Consider a post-take round where an agentic medicines-optimisation system presents a doctor with 41 prescribing actions. Each action carries a green confidence marker and a single approve control, with underlying reasoning hidden behind data the clinician lacks the time to reconstruct. The doctor clears the queue in under four minutes because the system has been correct for months. If the agent continues an anticoagulant at a dose inferred from an outdated weight, the approval is still recorded against the clinician's registration number.
This design functions exactly as intended, forcing a human to ratify a decision they did not make on information they cannot fully evaluate. Regulatory frameworks assume a human-in-the-loop model, placing responsibility on a named individual presumed to have authorized the act. In reality, these systems run human-on-the-loop, where the clinician monitors but does not gate each action. When an error surfaces, liability defaults to the out-of-the-loop reviewer whom the low error rate has made least vigilant.
The liability sink in procurement
In May 2024, the Master of the Rolls, Sir Geoffrey Vos, said a professional may be negligent for using AI and negligent for declining to use it. The EU AI Act addresses this by mandating that high-risk AI systems in healthcare be designed to enable effective human oversight and override capability. However, procurement frameworks at the facility level rarely require compliance with this mandate as a condition of purchase.
Healthcare leaders evaluating AI for executives and strategy must recognize that AI products are acquired by fragmented stakeholders, often without consulting clinical risk or patient safety functions. This fragmented acquisition process means operational AI scales faster than clinical AI because its return on investment is legible and its liability is lower. Consequently, efficiency gains accumulate before the accountability architecture problem is ever forced into the open.
Three structural failures sustain this accountability gap. First, procurement frameworks treat AI like standard equipment, evaluating cost and compliance rather than enforcing governance requirements as a condition of purchase. Second, operational AI scales faster than clinical AI because its return on investment is legible and its liability is lower, delaying scrutiny of the accountability architecture. Finally, when no governance layer is designed into deployment, accountability concentrates on the clinician at the checkpoint and the institution in the regulatory filing.
Why this matters for healthcare professionals
Healthcare professionals must demand that governance architecture be built into AI deployment from the start, rather than appended after the fact. Adding sign-offs to a saturated clinician produces approval theatre, spreading attention so thin that no real oversight occurs. Structured checkpoints belong only at genuine decision nodes, such as irreversible acts or high-consequence prescriptions. Redesigning procurement criteria to require accountability mapping ensures health systems can safely carry these tools, and professionals can explore resources on AI for healthcare to align deployment with clear lines of responsibility.
Your membership also unlocks:
